Sustainable Medicines Manufacturing Innovation: Collaborative R&D
29/08/2024Biomedical Catalyst 2024
03/09/2024Up to £540k
Project Value
Maximum 15 Months
Project Length
2nd October 2024
Competition Closes
As AI becomes more capable, it has the potential to power scientific breakthroughs, enhance global prosperity, and safeguard us from disasters. But only if it’s deployed wisely.
This funding call for Safeguarded AI solicits potential individuals or organisations interested in using ARIA's gatekeeper AI to build safeguarded products for domain-specific applications, such as optimising energy networks, clinical trials, or telecommunications networks.
Fund details
The programme is split into three technical areas (TAs). This competition is focused on TA3 - Applications.
TA3 applications will include two phases with this solicitation focusing on the first phase (£5.4 million funding pot). A second phase (£8.4 million funding pot) will launch in approximately one year.
TA3 solicits potential product developers (which could be individuals, entrepreneurs, existing entities, small, medium or large enterprises, nonprofit research institutions, etc.) as well as customer organisations (that is, operators in a relevant application domain) interested in using ARIA's gatekeeper AI workflow to build and apply safeguarded products for specific tasks in a specific sector.
Phase 1 will provide the funding to run initial “pilots” for 12-15 months, from which ARIA will choose a smaller number of projects to fund with a larger contribution in Phase 2.